{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:16:59Z","timestamp":1764656219550,"version":"build-2065373602"},"reference-count":33,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>COVID-19 and preeclampsia (preE) share the ANG-II mediated endothelial dysfunction, resulting from a significant dysregulation of RAS and an imbalanced proportion of anti-angiogenic and pro-angiogenic soluble plasmatic factors. Of note, an increased incidence of preE has been reported among COVID-19-infected mothers compared to the general pregnant population. The two most promising angiogenic markers are the soluble fms-like tyrosine kinase receptor-1 (sFlt-1), the major antiangiogenic factor, and the placental growth factor (PlGF), a powerful angiogenic factor. Since these markers have proven useful in the prediction, diagnosis, and severity of preE, this study aimed to evaluate their maternal serum levels in pregnancies complicated by SARS-CoV-2 infection and to assess their potential use to guide the management of these women. A retrospective analysis of SARS-CoV-2-positive pregnant women was performed. The serum levels of sFlt-1 and PlGF were collected at the diagnosis of SARS-CoV-2 infection at the hospital, before the beginning of steroid\/hydroxychloroquine and\/or antithrombotic therapy. The sFlt-1\/PlGF ratio was stratified using cut-off values clinically utilized in the diagnosis and prediction of preE (low &lt; 38, intermediate 38\u201385\/110* and high &gt;85\/110*, * if before or after the 34th week of gestation). A total of 57 women were included, of whom 20 (35%) had signs and symptoms of COVID-19 at hospital presentation and 37 (65%) were asymptomatic. None were vaccinated. The mean gestational age at diagnosis of SARS-CoV-2 infection was 32 weeks in symptomatic patients and 37 weeks and 5 days in asymptomatic ones (p = 0.089). sFlt-1 serum levels were higher in SARS-CoV-2 positive asymptomatic patients compared to women with COVID-19 related symptoms (4899 \u00b1 4357 pg\/mL vs. 3187 \u00b1 2426 pg\/mL, p = 0.005). sFlt-1\/PlGF at admission was &lt;38 in 18 of the 20 symptomatic women (90%) compared to 22 (59%) of the asymptomatic patients (p = 0.018). Of note, two of the three women admitted to the intensive care unit had a very low ratio (&lt;2). In turn, rates of patients with sFlt-1\/PlGF at admission &gt; 85\/110 were not significantly different between the two groups: 11% in asymptomatic patients (4\/37) vs. none of the symptomatic patients (p = 0.286), and all of them presented a placental dysfunction, like preE (n = 1) and FGR (n = 3). Of note, there were no stillbirths or maternal or neonatal deaths among symptomatic patients; also, no cases of preE, FGR, or small for gestational age neonates were diagnosed. In conclusion, our data suggest that SARS-CoV-2 infection during pregnancy could influence the angiogenic balance. A significant pathological alteration of the sFlt-1\/PlGF ratio cannot be identified during the symptomatic phase; however, if left untreated, SARS-CoV-2 infection could potentially trigger placental dysfunction.<\/jats:p>","DOI":"10.3390\/v14102207","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T02:10:27Z","timestamp":1665540627000},"page":"2207","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Imbalanced Angiogenesis in Pregnancies Complicated by SARS-CoV-2 Infection"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-9994","authenticated-orcid":false,"given":"Valentina","family":"Giardini","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, MBBM Foundation Onlus, San Gerardo Hospital, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6898-7217","authenticated-orcid":false,"given":"Sara","family":"Ornaghi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, MBBM Foundation Onlus, San Gerardo Hospital, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Gambacorti-Passerini","sequence":"additional","affiliation":[{"name":"Hematology Division, ASST-Monza, San Gerardo Hospital, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4968-1455","authenticated-orcid":false,"given":"Marco","family":"Casati","sequence":"additional","affiliation":[{"name":"Laboratory Medicine, ASST-Monza, San Gerardo Hospital, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Carrer","sequence":"additional","affiliation":[{"name":"Hematology Division, ASST-Monza, San Gerardo Hospital, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Acampora","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, MBBM Foundation Onlus, San Gerardo Hospital, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-901X","authenticated-orcid":false,"given":"Maria Viola","family":"Vasarri","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, MBBM Foundation Onlus, San Gerardo Hospital, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Arienti","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, MBBM Foundation Onlus, San Gerardo Hospital, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-0045","authenticated-orcid":false,"given":"Patrizia","family":"Vergani","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, MBBM Foundation Onlus, San Gerardo Hospital, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/postgradmedj-2020-138386","article-title":"SARS-CoV-2 and the pandemic of COVID-19","volume":"97","author":"Adil","year":"2021","journal-title":"Postgrad. Med. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e00133-20","DOI":"10.1128\/CMR.00133-20","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systemic Infection","volume":"34","author":"Synowiec","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jmv.25785","article-title":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19","volume":"92","author":"Cheng","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies","volume":"94","author":"Patel","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11154-021-09663-z","article-title":"Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19","volume":"23","author":"Cook","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6268276","DOI":"10.1155\/2018\/6268276","article-title":"Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction","volume":"2018","author":"Mayrink","year":"2018","journal-title":"Sci. World J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.preghy.2022.01.011","article-title":"Renin-angiotensin system in normal pregnancy and in preeclampsia: A comprehensive review","volume":"28","author":"Leal","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e12310","DOI":"10.14814\/phy2.12310","article-title":"Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemia\/hypoxia: Role of angiotensin II","volume":"3","author":"Murphy","year":"2015","journal-title":"Physiol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/micc.12093","article-title":"Regulation of placental angiogenesis","volume":"21","author":"Chen","year":"2014","journal-title":"Microcirculation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"354359","DOI":"10.1155\/2015\/354359","article-title":"Normal and pathological placental angiogenesis","volume":"2015","author":"Bardin","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1203\/01.PDR.0000159567.85157.B7","article-title":"Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia","volume":"57","author":"Maynard","year":"2005","journal-title":"Pediatr. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/1471-0528.16339","article-title":"Pre-eclampsia-like syndrome induced by severe COVID-19: A prospective observational study","volume":"127","author":"Mendoza","year":"2020","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.2020.19124","article-title":"Association of SARS-CoV-2 Test Status and Pregnancy Outcomes","volume":"324","author":"Ahlberg","year":"2020","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"289.e1","DOI":"10.1016\/j.ajog.2021.05.014","article-title":"Preeclampsia and COVID-19: Results from the INTERCOVID prospective longitudinal study","volume":"225","author":"Papageorghiou","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"E188","DOI":"10.1002\/ajh.25882","article-title":"Increased sFLT-1\/PlGF ratio in COVID-19: A novel link to angiotensin II-mediated endothelial dysfunction","volume":"95","author":"Giardini","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1002\/ajh.26037","article-title":"SFLT-1 levels in COVID-19 patients: Association with outcome and thrombosis","volume":"96","author":"Negro","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050500202493","article-title":"Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin","volume":"18","author":"Bujold","year":"2005","journal-title":"J. Matern.-Fetal Neonatal Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Espino-Y-Sosa, S., Martinez-Portilla, R.J., Torres-Torres, J., Solis-Paredes, J.M., Estrada-Gutierrez, G., Hernandez-Pacheco, J.A., Espejel-Nu\u00f1ez, A., Mateu-Rogell, P., Juarez-Reyes, A., and Lopez-Ceh, F.E. (2021). Novel Ratio Soluble Fms-like Tyrosine Kinase-1\/Angiotensin-II (sFlt-1\/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19. Viruses, 13.","DOI":"10.3390\/v13101906"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/uog.24798","article-title":"Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcome in pregnant women with COVID-19","volume":"59","author":"Poon","year":"2022","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"(2020). Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet. Gynecol., 135, e237\u2013e260.","DOI":"10.1097\/AOG.0000000000003891"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: A Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/14767058.2012.664889","article-title":"Neonatal growth charts","volume":"25","author":"Bertino","year":"2012","journal-title":"J. Matern.-Fetal Neonatal Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_26","first-page":"186","article-title":"Can similarities between the pathogenesis of preeclampsia and COVID-19 increase the understanding of COVID-19?","volume":"2","author":"Giardini","year":"2022","journal-title":"Int. J. Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajog.2021.07.009","article-title":"SARS-CoV-2 infection during pregnancy and risk of preeclampsia: A systematic review and meta-analysis","volume":"226","author":"Romero","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Giardini, V., Ornaghi, S., Acampora, E., Vasarri, M.V., Arienti, F., Gambacorti-Passerini, C., Casati, M., Carrer, A., and Vergani, P. (2021). Letter to the Editor: SFlt-1 and PlGF Levels in Pregnancies Complicated by SARS-CoV-2 Infection. Viruses, 13.","DOI":"10.3390\/v13122377"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/HYPERTENSIONAHA.116.08298","article-title":"Low Molecular Weight Heparin Improves Endothelial Function in Pregnant Women at High Risk of Preeclampsia","volume":"69","author":"McLaughlin","year":"2017","journal-title":"Hypertension"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamapediatrics.2021.1050","article-title":"Maternal and Neonatal Morbidity and Mortality Among Pregnant Women with and without COVID-19 Infection: The INTERCOVID Multinational Cohort Study","volume":"175","author":"Villar","year":"2021","journal-title":"JAMA Pediatr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"E540","DOI":"10.1503\/cmaj.202604","article-title":"The impact of COVID-19 on pregnancy outcomes: A systematic review and meta-analysis","volume":"193","author":"Wei","year":"2021","journal-title":"CMAJ Can. Med. Assoc. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1111\/aogs.14269","article-title":"Preterm birth among women with and without severe acute respiratory syndrome coronavirus 2 infection","volume":"100","author":"Blitz","year":"2021","journal-title":"Acta Obstet. Gynecol. Scand."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/10\/2207\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:47:38Z","timestamp":1760143658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/10\/2207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["v14102207"],"URL":"https:\/\/doi.org\/10.3390\/v14102207","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}